Brief: Diagonal Bio Q3 Operating Loss Narrows To SEK 1.2 Mln
31/10/2024 07:12
Oct 31 (Reuters) - Diagonal Bio AB DIABIO.ST :
* Q3 OPERATING PROFIT AMOUNTED TO -1 242 KSEK (-2 605 KSEK)
Source text: ID:nWkr3cLbBZ
Further company coverage: DIABIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Diagonal Bio AB
See all newsBrief: Diagonal Bio Approved For Delisting From Nasdaq First NGM
Brief: Diagonal Bio Gets Conditional Approval For Listing On NGM Nordic SME
Brief: Diagonal Bio Applies For Change Of Marketplace To NGM Nordic SME
Brief: Diagonal Bio Resolves On Directed Issue Of Units To All External Underwriters
Brief: Diagonal Bio Says Positive Pilot Test Results, Gets Order From Stallzet